Come visit us at
ADLM 2026 Meeting of the minds
At AliveDx, we aim to advance in-vitro diagnostics by putting the patients first, creating innovative solutions that enable laboratories and clinicians to shorten time to diagnosis.
The Wait Is Over. The Diagnostic Revolution Starts Here.
Booth #4337 — Come Witness It.
Your Patients Can’t Wait. Neither Should You
Explore how AliveDx delivers solutions across autoimmune disease, allergy and transfusion diagnostics to shorten time to results, provide clinical insights and improve your lab’s workflow.
Join us at ADLM 2026 in Anaheim, CA, USA
Conference Dates: July 28-30 2026
Anaheim Convention Center – Booth #4337
AliveDx solutions across autoimmune disease, allergy and transfusion diagnostics
Explore how MosaiQ® and LumiQ® deliver fast time to results and clinical insights while improving your lab’s workflow.
Syndromic multiplex testing for fast results
MosaiQ® is AliveDx’s fully automated, high-throughput platform for multiplex testing, combining advanced microarray technology with efficient laboratory workflows.
Automated IFA workflows from sample to result
LumiQ® supports autoimmune IFA testing with a compact, all-in-one workflow designed to help laboratories standardize reading, image capture, and interpretation.
Scientific Evidence Posters
Scientific evidence of MosaiQ® performance across Vasculitis, Rheumatic Diseases and Celiac Disease.
Our 3 ADLM posters will be presented during the same Clinical and Diagnostic Immunology poster session on Wednesday, July 29.
Poster SessionClinical and Diagnostic Immunology
Display DayWednesday, July 29
Display Time9:30 AM – 5:00 PM U.S. Pacific Time
Presentation Information1:30 – 2:30 PM U.S. Pacific Time
Analytical evaluation of a fully automated multiplex microarray immunoassay for simultaneous detection of anti-MPO, anti-PR3, and anti-GBM autoantibodies in a reference laboratory in Southern France.
Authors: Gerber Gomez, Guillaume Nardella, Claire Monat
Affiliations: AliveDx, Scientific & Medical Affairs, Eysins, Switzerland; Inovie Labosud Provence Secteur Analyses Specialisees Auto-immunite, Marseille, France.
Study: VAS Inovie, FR
Analytical evaluation of a fully automated multiplex microarray immunoassay for simultaneous detection of fifteen autoantibodies associated to autoimmune rheumatic diseases in a clinical laboratory in Kuwait.
Authors: Gerber Gomez, Haya Al-Kheder, Mohamed Elzallat, Abeer Al-Najadh
Affiliations: AliveDx, Scientific & Medical Affairs, Eysins, Switzerland; Immunology Unit, Laboratory Department, Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait.
Study: CTDplus Kuwait
Method Comparison and Clinical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay for the Detection of Celiac Disease Autoantibodies in a Pediatric Population
Authors: Jose Santiago, Kathy Phan, Paulina Ramos, Anthony Perez, Caleb Cornaby
Affiliations: AliveDx, Clinical & Scientific Affairs, Chicago, USA; AliveDx, Technical Services, Chicago, USA; Diagnostic Immunology and Flow Cytometry in the Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, USA.
Study: CD pediatric CHLA
